Written by PTB Reports, 2022, 8, 3, 105-112.
DOI: 10.5530/PTB.2022.8.14
Published: December 2022
Type: Review Article
Authors: Yousef Ahmed Alomi, Anhar Alyousef, Mohammed Mominul Islam, Maha Hussein Almadany, Bader Abdullah Alqannass, Eman Elsayed Younis, Rehab Ahmed Al Noaimi, and Hamidah Qasim Ali Abushomi
Author(s) affiliations:
Dr. Yousef Ahmed Alomi*, BSc. Pharm, MSc. Clin Pharm, BCPS, BCNSP, DiBA, CDE, Critical Care Clinical Pharmacist, TPN Clinical Pharmacist, Freelancer Business Planner, Content Editor, and Data Analyst, Riyadh, SAUDI ARABIA.
Anhar Alyousef, Pharm D, Innova Healthcare Company, Riyadh, SAUDI ARABIA.
Mohammed Mominul Islam, MBBS, MPH, MSC, Deputy Director, Department of Infection Prevention and Control (IPC), King Fahad Specialist Hospital, Tabuk, SAUDI ARABIA.
Maha Hussein Almadany, Bsc. Pharm, Health Care Quality Management Professional Diploma (HCQM), Pharmacy Quality Department, King Salman bin Abdulaziz Medical City, Al Madina Al Monwarah, SAUDI ARABIA.
Bader Abdullah Alqannass, Bsc. Pharm, MSc. Clin Pharm, Royal Commission Health Services Program, Jubail, SAUDI ARABIA.
Eman Elsayed Younis, Pharm.D, BCPS, A.Q (Cardiology), Senior Clinical Pharmacist, Saudi German Hospital Group, Madinah, Madinah, Saudi Arabia.
Rehab Ahmed Al Noaimi, BSc. Pharm, Salmanya Medical Complex, Manama, BAHRAIN.
Hamidah Qasim Ali Abushomi, BSc, MSc. Clin Pharm, Dammam Medical Complex, Dammam, SAUDI ARABIA.
Abstract
Objectives: In this study, we aimed to explore the Education and Training policy of pharmacy infection control as a new initiative project in Saudi Arabia. Methods: It is a narrative review of pharmacy infection control. The literature search was done using databases, including PubMed, Medline, and Google Scholar, about specific pharmacy practice infection control policies and procedures. The search time was from the 1960s to October 2021. The topic was in English and included narrative review, meta-analysis, systemic review, and guidelines across all hospitals and community pharmacy services. Moreover, the national and international guidelines of general research in hospital practice. The pharmacy research committee formulated and consisted of various experts, including clinical pharmacists, drug information pharmacists, and infection control specialists. Some authors drafted the policy and procedures, and others reviewed and corrected them. The additional author, an infection control specialist, revised the final document. The study emphasizes the Pharmacy infection control policy of Research Education and Training. Results: The Pharmacy Infection control Education and Training policy consisted of various items, including program objectives, admission requirements, teaching and education methodology, and Pharmacy infection control Education and Training steps in pharmacy practice. The education and training contained five models. Namely, hand hygiene and personal protective equipment, environment and workplace, employment immunization and occupational safety, pharmacy wastage and spill cleaning, pharmacoepidemiology with a pharmacy infection control surveillance, and pharmacy infection control quality management. Each model described Module description, Learning Objectives, Module Outlines, and Competency items. Conclusion: The pharmacy infection control policy of Research Education and Training is a new initiative for pharmacy career professionals. The Pharmacy infection control Education and Training pharmacy policy aims to improve infection control skills and encourage pharmacists’ compliance with infection control regulations in different places in the public and healthcare organizations. Therefore, education and training in pharmacy infection control policy are necessary for the pharmaceutical care services in Saudi Arabia.